Your browser doesn't support javascript.
loading
Risk Factors for In-Stent Stenosis After Flow Diverter Treatment of Intracranial Aneurysms: A Systematic Review and Meta-Analysis of 2350 Patients.
Abramyan, Arevik; Roychowdhury, Sudipta; Tarasova, Natalia; Sioutas, Georgios; Samaan, Mena; Mangla, Sherry; Sundararajan, Srihari; Gupta, Gaurav.
Affiliation
  • Abramyan A; Department of Neurosurgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
  • Roychowdhury S; Department of Interventional Radiology, Robert Wood Johnson Medical School, University Radiology, New Brunswick, New Jersey, USA.
  • Tarasova N; Department of Anesthesiology, Geisinger Medical Center, Danville, Pennsylvania, USA.
  • Sioutas G; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Samaan M; Department of Neurosurgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
  • Mangla S; IQVIA, Bangalore, India.
  • Sundararajan S; Department of Interventional Radiology, Robert Wood Johnson Medical School, University Radiology, New Brunswick, New Jersey, USA.
  • Gupta G; Department of Neurosurgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Neurosurgery ; 2024 Oct 02.
Article in En | MEDLINE | ID: mdl-39356151
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Recent advances in flow diverter (FD) therapy for intracranial aneurysms have highlighted the need to evaluate risk factors for in-stent stenosis (ISS), a potentially serious complication. This meta-analysis aims to identify risk factors associated with an increased risk of ISS after FD treatment.

METHODS:

PubMed, Web of Science, Embase, and SCOPUS databases were systematically searched for studies reporting ISS rates and risk factors after FD therapy for intracranial aneurysms. Odds ratios were calculated using random-effects models to assess potential risk factors associated with ISS.

RESULTS:

Ten studies involving 2350 patients with 2441 aneurysms were included. Younger age (P = .006) and male sex (P = .003) were associated with higher ISS risk. Smoking also increased the risk (P = .02). Aneurysm location in the posterior circulation (P < .00001) and fusiform morphology (P < .00001) were significant risk factors for ISS, as were ruptured aneurysms (P = .05). Hypertension, hyperlipidemia, diabetes, allergies, and alcohol abuse, as well as aneurysm size, neck width, and parent artery diameter, did not affect ISS risk. Procedural factors like balloon angioplasty, multiple FDs, or FD/coil combinations were not significantly associated with ISS.

CONCLUSION:

This meta-analysis identified both nonmodifiable (younger age, male sex) and modifiable (smoking) patient factors, as well as high-risk aneurysm characteristics (posterior circulation, fusiform, ruptured), associated with an increased risk of ISS after FD treatment. These findings highlight the importance of tailored monitoring and management approaches for optimizing outcomes in FD therapy.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Neurosurgery Year: 2024 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Neurosurgery Year: 2024 Document type: Article Affiliation country: United States Country of publication: United States